We are live on
!
Find out more
IHM
Iguana Healthcare Management Portfolio holdings
AUM
$152M
1-Year Est. Return
48.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.41%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$62.7M
(-20%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-9.27%
Top 10 Holdings %
Top 10 Hldgs %
42.61%
Holding
95
New
26
Increased
21
Reduced
16
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$7.51M |
| 2 |
Bausch Health
BHC
|
+$7M |
| 3 |
McKesson
MCK
|
+$6.36M |
| 4 |
AET
Aetna Inc
AET
|
+$5.78M |
| 5 |
Biogen
BIIB
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ultragenyx Pharmaceutical
RARE
|
+$10.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$7.45M |
| 3 |
STJ
St Jude Medical
STJ
|
+$7.31M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.28M |
| 5 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
+$4.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.13% |
| 2 | Financials | 2.15% |
| 3 | Consumer Staples | 1.24% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Elevance Health
ELV
$84.3B
| $14M | 5.51% |
100,000
+50,000
| +100% | +$7.51M |
|
2
CALL
DexCom
DXCM
$31.3B
| $12.9M | 5.07% |
+60,000
| New | +$1.34M |
|
3
CALL
Pfizer
PFE
$148B
| $12.6M | 4.94% |
421,600
| – | – |
|
|
4
Bausch Health
BHC
$2.24B
| $11.6M | 4.56% |
65,000
+30,000
| +86% | +$7M |
|
|
5
Ultragenyx Pharmaceutical
RARE
$2.48B
| $10.6M | 4.17% |
110,000
-90,000
| -45% | -$10.3M |
|
6
Gilead Sciences
GILD
$161B
| $9.82M | 3.86% |
100,000
| – | – |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $9.73M | 3.83% |
90,000
-60,000
| -40% | -$7.45M |
|
|
8
Pfizer
PFE
$148B
| $9.42M | 3.71% |
316,200
+105,400
| +50% | +$3.38M |
|
9
Amgen
AMGN
$217B
| $8.99M | 3.54% |
65,000
+5,000
| +8% | +$788K |
|
|
10
Biogen
BIIB
$30.2B
| $8.75M | 3.44% |
30,000
+15,000
| +100% | +$4.95M |
|
11
Edwards Lifesciences
EW
$51B
| $8.53M | 3.35% |
360,000
+150,000
| +71% | +$3.62M |
|
|
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
| $6.07M | 2.39% |
75,000
-25,000
| -25% | -$2.18M |
|
13
Teva Pharmaceuticals
TEVA
$40.2B
| $5.65M | 2.22% |
100,000
+25,000
| +33% | +$1.62M |
|
|
14
McKesson
MCK
$99.4B
| $5.55M | 2.18% |
+30,000
| New | +$6.36M |
|
|
AET
15
DELISTED
Aetna Inc
AET
| $5.47M | 2.15% |
+50,000
| New | +$5.78M |
|
16
Cigna
CI
$72B
| $5.4M | 2.12% |
40,000
| – | – |
|
|
NVDQ
17
DELISTED
Novadaq Technologies Inc.
NVDQ
| $5.21M | 2.05% |
500,000
+100,000
| +25% | +$1.18M |
|
18
Medtronic
MDT
$110B
| $5.02M | 1.97% |
75,000
-25,000
| -25% | -$1.84M |
|
|
ENDP
19
DELISTED
Endo International plc
ENDP
| $4.85M | 1.91% |
70,000
+45,000
| +180% | +$3.6M |
|
20
Viatris
VTRS
$19.7B
| $4.43M | 1.74% |
110,000
+35,000
| +47% | +$1.95M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.96M | 1.56% |
200,000
| – | – |
|
22
CALL
Merck
MRK
$317B
| $3.7M | 1.46% |
+78,600
| New | +$4.18M |
|
|
GWPH
23
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.65M | 1.44% |
40,000
-5,000
| -11% | -$556K |
|
|
LJPC
24
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.47M | 1.37% |
+125,000
| New | +$3.94M |
|
25
CALL
AbbVie
ABBV
$429B
| $3.26M | 1.28% |
+60,000
| New | +$3.91M |
|
Similar funds
HWP
PAM
USG2
LCM
FPF
FIAS
CII
OPWM
Iguana Healthcare Management's Q3 2015 Portfolio in Review
As of Q3 2015, Iguana Healthcare Management held 95 positions worth $254M, down 20% from $317M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Iguana Healthcare Management withdrew a net $23.6M in Q3 2015, closing 24 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $7.31M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Iguana Healthcare Management opened a new position in McKesson worth $5.55M.
- Iguana Healthcare Management's largest Q3 2015 buy was McKesson: 30,000 shares worth $5.55M.
- Iguana Healthcare Management added most to Elevance Health in Q3 2015, an estimated $7.51M increase.
- Iguana Healthcare Management's biggest Q3 2015 reduction was Ultragenyx Pharmaceutical, cutting an estimated $10.3M.
- Iguana Healthcare Management fully exited St Jude Medical in Q3 2015, selling an estimated $7.31M.
- Iguana Healthcare Management's ten largest holdings make up 43% of its $254M portfolio in Q3 2015.
- Iguana Healthcare Management opened 26 new positions and closed 24 in Q3 2015.
- Iguana Healthcare Management's portfolio value fell 20% quarter-over-quarter to $254M.
Based on Iguana Healthcare Management's 13F filing for Q3 2015, filed 16 Nov 2015.